nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—ABCB1—adrenal gland cancer	0.669	1	CbGaD
Imipramine—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.011	0.104	CbGeAlD
Imipramine—HTR7—sympathetic nervous system—adrenal gland cancer	0.0106	0.101	CbGeAlD
Imipramine—HTR7—vein—adrenal gland cancer	0.00992	0.0942	CbGeAlD
Imipramine—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00661	0.0628	CbGeAlD
Imipramine—HTR2A—vein—adrenal gland cancer	0.00619	0.0587	CbGeAlD
Imipramine—CYP2C19—urine—adrenal gland cancer	0.00567	0.0538	CbGeAlD
Imipramine—CYP1A2—urine—adrenal gland cancer	0.00463	0.044	CbGeAlD
Imipramine—CYP2E1—urine—adrenal gland cancer	0.00417	0.0396	CbGeAlD
Imipramine—HTR2A—urine—adrenal gland cancer	0.00362	0.0344	CbGeAlD
Imipramine—KCND2—pituitary gland—adrenal gland cancer	0.0036	0.0342	CbGeAlD
Imipramine—CYP3A4—urine—adrenal gland cancer	0.00335	0.0318	CbGeAlD
Imipramine—CYP2D6—urine—adrenal gland cancer	0.0033	0.0313	CbGeAlD
Imipramine—KCND3—cardiac atrium—adrenal gland cancer	0.00321	0.0305	CbGeAlD
Imipramine—KCND3—adrenal gland—adrenal gland cancer	0.0028	0.0266	CbGeAlD
Imipramine—SLC22A4—pituitary gland—adrenal gland cancer	0.00165	0.0157	CbGeAlD
Imipramine—SLC22A3—gonad—adrenal gland cancer	0.00154	0.0146	CbGeAlD
Imipramine—SLC22A4—adrenal gland—adrenal gland cancer	0.00148	0.014	CbGeAlD
Imipramine—SLC22A3—adrenal gland—adrenal gland cancer	0.00134	0.0128	CbGeAlD
Imipramine—SLC6A2—gonad—adrenal gland cancer	0.00132	0.0126	CbGeAlD
Imipramine—HTR7—gonad—adrenal gland cancer	0.00127	0.0121	CbGeAlD
Imipramine—KCNH2—cardiac atrium—adrenal gland cancer	0.00119	0.0113	CbGeAlD
Imipramine—CYP2B6—adrenal cortex—adrenal gland cancer	0.00118	0.0112	CbGeAlD
Imipramine—DRD2—pituitary gland—adrenal gland cancer	0.00118	0.0112	CbGeAlD
Imipramine—HTR1A—adrenal gland—adrenal gland cancer	0.00116	0.011	CbGeAlD
Imipramine—KCNH2—pituitary gland—adrenal gland cancer	0.00116	0.011	CbGeAlD
Imipramine—SLC6A2—adrenal gland—adrenal gland cancer	0.00115	0.0109	CbGeAlD
Imipramine—HTR7—adrenal gland—adrenal gland cancer	0.00111	0.0105	CbGeAlD
Imipramine—ADRA1A—adrenal gland—adrenal gland cancer	0.00107	0.0102	CbGeAlD
Imipramine—KCNH2—adrenal gland—adrenal gland cancer	0.00103	0.00982	CbGeAlD
Imipramine—CYP2B6—gonad—adrenal gland cancer	0.000974	0.00925	CbGeAlD
Imipramine—CYP2B6—adrenal gland—adrenal gland cancer	0.000849	0.00806	CbGeAlD
Imipramine—HRH1—adrenal gland—adrenal gland cancer	0.000829	0.00787	CbGeAlD
Imipramine—CYP2E1—adrenal gland—adrenal gland cancer	0.000797	0.00757	CbGeAlD
Imipramine—HTR2A—gonad—adrenal gland cancer	0.000795	0.00754	CbGeAlD
Imipramine—HTR2A—pituitary gland—adrenal gland cancer	0.000775	0.00736	CbGeAlD
Imipramine—HTR2A—adrenal gland—adrenal gland cancer	0.000693	0.00658	CbGeAlD
Imipramine—Epinastine—ABCB1—adrenal gland cancer	0.000668	0.158	CrCbGaD
Imipramine—ABCB1—adrenal cortex—adrenal gland cancer	0.000629	0.00597	CbGeAlD
Imipramine—Maprotiline—ABCB1—adrenal gland cancer	0.000575	0.136	CrCbGaD
Imipramine—ABCB1—gonad—adrenal gland cancer	0.000521	0.00494	CbGeAlD
Imipramine—ABCB1—pituitary gland—adrenal gland cancer	0.000508	0.00482	CbGeAlD
Imipramine—Triflupromazine—ABCB1—adrenal gland cancer	0.000503	0.119	CrCbGaD
Imipramine—ABCB1—adrenal gland—adrenal gland cancer	0.000454	0.00431	CbGeAlD
Imipramine—Carbamazepine—ABCB1—adrenal gland cancer	0.00042	0.0991	CrCbGaD
Imipramine—Clomipramine—ABCB1—adrenal gland cancer	0.000354	0.0835	CrCbGaD
Imipramine—Trimipramine—ABCB1—adrenal gland cancer	0.000325	0.0768	CrCbGaD
Imipramine—Promethazine—ABCB1—adrenal gland cancer	0.000313	0.074	CrCbGaD
Imipramine—Doxepin—ABCB1—adrenal gland cancer	0.00031	0.0732	CrCbGaD
Imipramine—Desipramine—ABCB1—adrenal gland cancer	0.000284	0.0672	CrCbGaD
Imipramine—Chlorpromazine—ABCB1—adrenal gland cancer	0.000242	0.0573	CrCbGaD
Imipramine—Amitriptyline—ABCB1—adrenal gland cancer	0.00024	0.0566	CrCbGaD
Imipramine—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	4.19e-05	0.000189	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	4.17e-05	0.000188	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—ABCB1—adrenal gland cancer	4.16e-05	0.000188	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IGF2—adrenal gland cancer	4.13e-05	0.000186	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—GNAS—adrenal gland cancer	4.09e-05	0.000185	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	4.07e-05	0.000184	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TERT—adrenal gland cancer	4.05e-05	0.000183	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	4.04e-05	0.000183	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TERT—adrenal gland cancer	4.04e-05	0.000183	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MED12—adrenal gland cancer	4.02e-05	0.000181	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IGF1R—adrenal gland cancer	3.99e-05	0.00018	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.98e-05	0.00018	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—GNAS—adrenal gland cancer	3.96e-05	0.000179	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	3.93e-05	0.000178	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MED12—adrenal gland cancer	3.92e-05	0.000177	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—ABCB1—adrenal gland cancer	3.88e-05	0.000175	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	3.88e-05	0.000175	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	3.87e-05	0.000175	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	3.87e-05	0.000175	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	3.86e-05	0.000175	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	3.86e-05	0.000174	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	3.85e-05	0.000174	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	3.83e-05	0.000173	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	3.82e-05	0.000172	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	3.8e-05	0.000172	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	3.8e-05	0.000172	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	3.8e-05	0.000172	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	3.79e-05	0.000171	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	3.79e-05	0.000171	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	3.78e-05	0.000171	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	3.77e-05	0.00017	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	3.73e-05	0.000169	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	3.73e-05	0.000169	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	3.72e-05	0.000168	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	3.71e-05	0.000168	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MED12—adrenal gland cancer	3.69e-05	0.000167	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	3.65e-05	0.000165	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—GNAS—adrenal gland cancer	3.65e-05	0.000165	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—PTGS2—adrenal gland cancer	3.63e-05	0.000164	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	3.6e-05	0.000163	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.59e-05	0.000162	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—ABCB1—adrenal gland cancer	3.59e-05	0.000162	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	3.58e-05	0.000162	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	3.57e-05	0.000161	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	3.57e-05	0.000161	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	3.55e-05	0.000161	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	3.55e-05	0.00016	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—BAD—adrenal gland cancer	3.52e-05	0.000159	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—BAD—adrenal gland cancer	3.52e-05	0.000159	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	3.51e-05	0.000159	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	3.5e-05	0.000158	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	3.49e-05	0.000158	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	3.48e-05	0.000157	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	3.48e-05	0.000157	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	3.46e-05	0.000156	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	3.45e-05	0.000156	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	3.44e-05	0.000155	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	3.44e-05	0.000155	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—PTGS2—adrenal gland cancer	3.43e-05	0.000155	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	3.43e-05	0.000155	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	3.4e-05	0.000153	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	3.32e-05	0.00015	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	3.31e-05	0.00015	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	3.28e-05	0.000148	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—POMC—adrenal gland cancer	3.24e-05	0.000147	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—POMC—adrenal gland cancer	3.24e-05	0.000146	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.24e-05	0.000146	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.24e-05	0.000146	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	3.22e-05	0.000146	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	3.22e-05	0.000145	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	3.21e-05	0.000145	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—BRAF—adrenal gland cancer	3.2e-05	0.000145	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	3.2e-05	0.000145	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	3.2e-05	0.000144	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	3.18e-05	0.000144	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	3.17e-05	0.000143	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	3.16e-05	0.000143	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	3.16e-05	0.000143	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GNAS—adrenal gland cancer	3.14e-05	0.000142	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	3.13e-05	0.000141	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MED12—adrenal gland cancer	3.13e-05	0.000141	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	3.11e-05	0.00014	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—EGFR—adrenal gland cancer	3.11e-05	0.00014	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	3.1e-05	0.00014	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	3.1e-05	0.00014	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	3.09e-05	0.00014	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	3.08e-05	0.000139	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	3.08e-05	0.000139	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	3.08e-05	0.000139	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GNAS—adrenal gland cancer	3.08e-05	0.000139	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	3.07e-05	0.000139	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	3.06e-05	0.000138	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	3.06e-05	0.000138	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	3.06e-05	0.000138	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	3.05e-05	0.000138	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	3.05e-05	0.000138	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	3.04e-05	0.000137	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	3.03e-05	0.000137	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	3.02e-05	0.000137	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	3.02e-05	0.000136	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	3.02e-05	0.000136	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	3.01e-05	0.000136	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	3e-05	0.000135	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	2.99e-05	0.000135	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	2.99e-05	0.000135	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	2.99e-05	0.000135	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	2.98e-05	0.000135	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	2.98e-05	0.000135	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	2.95e-05	0.000133	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	2.94e-05	0.000133	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	2.93e-05	0.000132	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	2.93e-05	0.000132	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	2.93e-05	0.000132	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	2.89e-05	0.000131	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.86e-05	0.000129	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—POMC—adrenal gland cancer	2.86e-05	0.000129	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.86e-05	0.000129	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—POMC—adrenal gland cancer	2.86e-05	0.000129	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	2.85e-05	0.000129	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	2.81e-05	0.000127	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.8e-05	0.000126	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	2.76e-05	0.000124	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	2.72e-05	0.000123	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.7e-05	0.000122	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—POMC—adrenal gland cancer	2.66e-05	0.00012	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	2.64e-05	0.000119	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	2.63e-05	0.000119	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	2.61e-05	0.000118	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	2.59e-05	0.000117	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	2.59e-05	0.000117	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	2.58e-05	0.000117	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	2.57e-05	0.000116	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	2.56e-05	0.000116	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	2.54e-05	0.000115	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	2.53e-05	0.000114	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	2.48e-05	0.000112	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—POMC—adrenal gland cancer	2.46e-05	0.000111	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.42e-05	0.000109	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	2.4e-05	0.000108	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	2.39e-05	0.000108	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	2.38e-05	0.000107	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	2.37e-05	0.000107	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	2.36e-05	0.000107	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	2.33e-05	0.000105	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.32e-05	0.000105	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CTNNB1—adrenal gland cancer	2.32e-05	0.000105	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	2.31e-05	0.000104	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	2.3e-05	0.000104	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	2.29e-05	0.000103	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	2.29e-05	0.000103	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	2.29e-05	0.000103	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	2.28e-05	0.000103	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	2.28e-05	0.000103	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PTGS2—adrenal gland cancer	2.28e-05	0.000103	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	2.26e-05	0.000102	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	2.25e-05	0.000102	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	2.25e-05	0.000101	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	2.24e-05	0.000101	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.23e-05	0.000101	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	2.23e-05	0.000101	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	2.21e-05	9.98e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	2.2e-05	9.95e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	2.19e-05	9.89e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.18e-05	9.87e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	2.18e-05	9.87e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.14e-05	9.68e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PTGS2—adrenal gland cancer	2.12e-05	9.6e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—POMC—adrenal gland cancer	2.12e-05	9.56e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	2.11e-05	9.52e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	2.09e-05	9.45e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	2.08e-05	9.41e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	2.07e-05	9.37e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—POMC—adrenal gland cancer	2.07e-05	9.36e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	2.07e-05	9.35e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	2.06e-05	9.32e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	2.06e-05	9.29e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	2.05e-05	9.25e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	2.04e-05	9.23e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	2.04e-05	9.21e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	2.04e-05	9.2e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	2.03e-05	9.18e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	2.03e-05	9.18e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	2.02e-05	9.12e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	2.01e-05	9.09e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	2.01e-05	9.06e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.99e-05	8.97e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	1.98e-05	8.95e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	1.98e-05	8.92e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	1.97e-05	8.89e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	1.97e-05	8.88e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PTGS2—adrenal gland cancer	1.96e-05	8.86e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	1.95e-05	8.81e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	1.94e-05	8.78e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	1.85e-05	8.36e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—EGFR—adrenal gland cancer	1.83e-05	8.29e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	1.83e-05	8.28e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	1.82e-05	8.2e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.76e-05	7.96e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	1.73e-05	7.82e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.71e-05	7.74e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	1.71e-05	7.7e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	1.69e-05	7.63e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	1.66e-05	7.49e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	1.65e-05	7.47e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.63e-05	7.37e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.6e-05	7.22e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.56e-05	7.05e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	1.56e-05	7.04e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—adrenal gland cancer	1.54e-05	6.96e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—adrenal gland cancer	1.54e-05	6.95e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.5e-05	6.8e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.48e-05	6.69e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.48e-05	6.67e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.47e-05	6.65e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.47e-05	6.64e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	1.47e-05	6.63e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.45e-05	6.57e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	1.45e-05	6.56e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.45e-05	6.55e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.43e-05	6.45e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.4e-05	6.33e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	1.39e-05	6.29e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	1.36e-05	6.13e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	1.35e-05	6.1e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	1.31e-05	5.91e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	1.29e-05	5.84e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.28e-05	5.76e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—POMC—adrenal gland cancer	1.25e-05	5.63e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.25e-05	5.62e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	1.19e-05	5.39e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.17e-05	5.3e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	1.17e-05	5.3e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	1.17e-05	5.29e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	1.17e-05	5.27e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	1.16e-05	5.25e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	1.15e-05	5.2e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	1.15e-05	5.19e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	1.14e-05	5.15e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	1.13e-05	5.12e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	1.09e-05	4.9e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	1e-05	4.52e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	9.94e-06	4.49e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	9.85e-06	4.45e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	9.83e-06	4.44e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	9.8e-06	4.43e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	9.77e-06	4.41e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	9.67e-06	4.37e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	9.64e-06	4.36e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—POMC—adrenal gland cancer	9.62e-06	4.34e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	7.67e-06	3.47e-05	CbGpPWpGaD
